Monocyte chemoattractant protein-1 (MCP-1)/CCL2 secreted by hepatic myofibroblasts promotes migration and invasion of human hepatoma cells - PubMed (original) (raw)
. 2010 Mar 1;126(5):1095-108.
doi: 10.1002/ijc.24800.
Nadine Suffee, Hanna Hlawaty, Oualid Haddad, Faten Charni, Christelle Laguillier, Roger Vassy, Loïc Martin, Pierre-Olivier Schischmanoff, Liliane Gattegno, Olivier Oudar, Angela Sutton, Nathalie Charnaux
Affiliations
- PMID: 19642141
- DOI: 10.1002/ijc.24800
Monocyte chemoattractant protein-1 (MCP-1)/CCL2 secreted by hepatic myofibroblasts promotes migration and invasion of human hepatoma cells
Maylis Dagouassat et al. Int J Cancer. 2010.
Abstract
The aim of our study was to investigate whether myofibroblasts and the chemokine monocyte chemoattractant protein-1 (MCP-1)/CCL2 may play a role in hepatocellular carcinoma progression. We observed that hepatic myofibroblast LI90 cells express MCP-1/CCL2 mRNA and secrete this chemokine. Moreover, myofibroblast LI90 cell-conditioned medium (LI90-CM) induces human hepatoma Huh7 cell migration and invasion. These effects are strongly reduced when a MCP-1/CCL2-depleted LI90-CM was used. We showed that MCP-1/CCL2 induces Huh7 cell migration and invasion through its G-protein-coupled receptor CCR2 and, to a lesser extent, through CCR1 only at high MCP-1/CCL2 concentrations. MCP-1/CCL2's chemotactic activities rely on tyrosine phosphorylation of focal adhesion components and depend on matrix metalloproteinase (MMP)-2 and MMP-9. Furthermore, we observed that Huh7 cell migration and invasion induced by the chemokine are strongly inhibited by heparin, by beta-D-xyloside treatment of cells and by anti-syndecan-1 and -4 antibodies. Finally, we developed a 3-dimensional coculture model of myofibroblast LI90 and Huh7 cells and demonstrated that MCP-1/CCL2 and its membrane partners, CCR1 and CCR2, may be involved in the formation of mixed hepatoma-myofibroblast spheroids. In conclusion, our data show that human liver myofibroblasts act on hepatoma cells in a paracrine manner to increase their invasiveness and suggest that myofibroblast-derived MCP-1/CCL2 could be involved in the pathogenesis of hepatocellular carcinoma.
Similar articles
- Stromal cell-derived factor-1/chemokine (C-X-C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasion.
Sutton A, Friand V, Brulé-Donneger S, Chaigneau T, Ziol M, Sainte-Catherine O, Poiré A, Saffar L, Kraemer M, Vassy J, Nahon P, Salzmann JL, Gattegno L, Charnaux N. Sutton A, et al. Mol Cancer Res. 2007 Jan;5(1):21-33. doi: 10.1158/1541-7786.MCR-06-0103. Mol Cancer Res. 2007. PMID: 17259344 - Glycosaminoglycans and their synthetic mimetics inhibit RANTES-induced migration and invasion of human hepatoma cells.
Sutton A, Friand V, Papy-Garcia D, Dagouassat M, Martin L, Vassy R, Haddad O, Sainte-Catherine O, Kraemer M, Saffar L, Perret GY, Courty J, Gattegno L, Charnaux N. Sutton A, et al. Mol Cancer Ther. 2007 Nov;6(11):2948-58. doi: 10.1158/1535-7163.MCT-07-0114. Mol Cancer Ther. 2007. PMID: 18025279 - Syndecan-1 and syndecan-4 are involved in RANTES/CCL5-induced migration and invasion of human hepatoma cells.
Charni F, Friand V, Haddad O, Hlawaty H, Martin L, Vassy R, Oudar O, Gattegno L, Charnaux N, Sutton A. Charni F, et al. Biochim Biophys Acta. 2009 Oct;1790(10):1314-26. doi: 10.1016/j.bbagen.2009.07.015. Epub 2009 Jul 24. Biochim Biophys Acta. 2009. PMID: 19632304 - More Than Just Attractive: How CCL2 Influences Myeloid Cell Behavior Beyond Chemotaxis.
Gschwandtner M, Derler R, Midwood KS. Gschwandtner M, et al. Front Immunol. 2019 Dec 13;10:2759. doi: 10.3389/fimmu.2019.02759. eCollection 2019. Front Immunol. 2019. PMID: 31921102 Free PMC article. Review. - Interrelationships between paraoxonase-1 and monocyte chemoattractant protein-1 in the regulation of hepatic inflammation.
Camps J, Marsillach J, Rull A, Alonso-Villaverde C, Joven J. Camps J, et al. Adv Exp Med Biol. 2010;660:5-18. doi: 10.1007/978-1-60761-350-3_2. Adv Exp Med Biol. 2010. PMID: 20221866 Review.
Cited by
- Role of chemokines in hepatocellular carcinoma (Review).
Xue D, Zheng Y, Wen J, Han J, Tuo H, Liu Y, Peng Y. Xue D, et al. Oncol Rep. 2021 Mar;45(3):809-823. doi: 10.3892/or.2020.7906. Epub 2020 Dec 22. Oncol Rep. 2021. PMID: 33650640 Free PMC article. Review. - CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands.
Korbecki J, Grochans S, Gutowska I, Barczak K, Baranowska-Bosiacka I. Korbecki J, et al. Int J Mol Sci. 2020 Oct 15;21(20):7619. doi: 10.3390/ijms21207619. Int J Mol Sci. 2020. PMID: 33076281 Free PMC article. Review. - TGF-beta in the pathogenesis and prevention of disease: a matter of aneurysmic proportions.
Dietz HC. Dietz HC. J Clin Invest. 2010 Feb;120(2):403-7. doi: 10.1172/JCI42014. Epub 2010 Jan 25. J Clin Invest. 2010. PMID: 20101091 Free PMC article. - CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of the Ligands of Receptors CCR1, CCR2, CCR3, and CCR4.
Korbecki J, Kojder K, Simińska D, Bohatyrewicz R, Gutowska I, Chlubek D, Baranowska-Bosiacka I. Korbecki J, et al. Int J Mol Sci. 2020 Nov 9;21(21):8412. doi: 10.3390/ijms21218412. Int J Mol Sci. 2020. PMID: 33182504 Free PMC article. Review. - Targeting CCR2 with its antagonist suppresses viability, motility and invasion by downregulating MMP-9 expression in non-small cell lung cancer cells.
An J, Xue Y, Long M, Zhang G, Zhang J, Su H. An J, et al. Oncotarget. 2017 Jun 13;8(24):39230-39240. doi: 10.18632/oncotarget.16837. Oncotarget. 2017. PMID: 28424406 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous